reports
- Carole Braudeau
AXA AXA
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
FNAC FNAC DARTY SA
GRF GRIFOLS S.A. CLASS A
UCG UNICREDIT S.P.A.
ONTEX ONTEX GROUP N.V.
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
CLNX CELLNEX TELECOM S.A.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
SYAB SYNLAB AG
SPM SAIPEM S.P.A.
- Carole Braudeau
AXA AXA
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
FNAC FNAC DARTY SA
GRF GRIFOLS S.A. CLASS A
UCG UNICREDIT S.P.A.
ONTEX ONTEX GROUP N.V.
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
CLNX CELLNEX TELECOM S.A.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
SYAB SYNLAB AG
SPM SAIPEM S.P.A.
- Guy Sips
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Thomas Couvreur
- Wim Hoste
- Jacob Mekhael
Inventiva FIRST LOOK: Completes NATiV3 enrolment, topline results pinn...
Inventiva announced the completion of patient enrolment in its phase 3 (NATiV3) trial of lanifibranor (pan-PPAR agonist) in MASH. This is a key milestone, particularly in the context of the difficulties associated with MASH trial recruitment. As a result, the timeline for the topline readout is now pinned to 2H26 taking into account the 72 weeks treatment period. Subject to the second tranche of ~€ 116m from the financing announced in October 2024, which is expected to be triggered in 2Q25, Inve...
- Wim Hoste
Ontex FIRST LOOK: Closing divestment of Brazilian business
Ontex has closed the earlier announced divestment of its Brazilian business, with closing of the Turkish business still on the agenda (scheduled for 3Q). Closing the Turkish divestment will complete the strategic transformation towards becoming a private-label focussed personal hygiene player in Europe and North America. Whilst Ontex is an established market leader in Europe, it is a challenger in North America which is characterized by much lower penetration of private label products. Whilst th...
- Felix Fischer
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Tanvi Arora
- Trung Nguyen
Inventiva announces completion of enrollment in the Phase 3 NATiV3 cli...
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory approval Daix (France), New York City (New York, United States), April 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical compan...
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3...
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoirePrincipaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires d’autorisation de mise sur le marché Daix (France), New York City (New York, États-Unis), le 1 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Sociét...
Ontex completes the divestment of its Brazilian business to Softys
Ontex completes the divestment of its Brazilian business to Softys Aalst, Belgium, April 1, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care products, announces that it has completed the divestment of its Brazilian business activities to Softys S.A., a personal hygiene company with operations across Latin America and a wholly-owned subsidiary of Empresas CMPC S.A., headquartered in Chile. The transaction includes Ontex’s business in Brazil and its manufacturing facility in Senador Canedo in the State of Goiás. The business develops, ...
Ontex voltooit de verkoop van haar Braziliaanse activiteiten aan Softy...
Ontex voltooit de verkoop van haar Braziliaanse activiteiten aan Softys Aalst, België, 1 april 2025 – Ontex Group NV (Euronext Brussel: ONTEX), een toonaangevende ontwikkelaar en producent van persoonlijke verzorgingsproducten, kondigt aan dat het de verkoop heeft voltooid van haar Braziliaanse bedrijfsactiviteiten aan Softys S.A., een bedrijf voor persoonlijke hygiëne met activiteiten in heel Latijns-Amerika. Softys is een volledige dochteronderneming van Empresas CMPC S.A., met hoofdzetel in Chili. De transactie omvat de activiteiten van Ontex in Brazilië en de productievestiging in Se...
Ontex Group NV announces the results of its cash tender offer for its...
Ontex Group NV announces the results of its cash tender offer for its outstanding €580,000,000 3.500% senior notes due 2026 Not for release, publication or distribution in or into, or to any person located or resident in or at any address in, the United States of America or to any person located or resident in any other jurisdiction where it is unlawful to distribute this press release, the Results Announcement or the Tender Offer Memorandum (each as defined below) or to any persons to whom it is otherwise unlawful to send this press release, the Results Announcement or the Tender Offe...
Ontex Group NV kondigt de resultaten aan van het aanbod tot aankoop in...
Ontex Group NV kondigt de resultaten aan van het aanbod tot aankoop in contanten van diens uitstaande €580.000.000 3,500% senior obligaties met vervaldag in 2026 Niet voor vrijgave, publicatie of verspreiding in of naar, of aan enige persoon gevestigd of woonachtig in of op enig adres in, de Verenigde Staten van Amerika of aan enige persoon gevestigd of woonachtig in enig ander rechtsgebied waar het onwettig is om dit persbericht, de Resultatenaankondiging of het Tender Offer Memorandum (elk zoals hieronder gedefinieerd) te verspreiden of aan enige personen aan wie het anderszins onwett...
Reporting on acquisition of treasury shares
Reporting on acquisition of treasury shares Regulated information Aalst, Belgium, March 31, 2025 – In accordance with article 8:4 of the Royal Decree of April 2, 2019 executing the Belgian Code of Companies and Associations, Ontex hereby discloses information in relation to its program to buy back treasury shares, which was announced on November 25, 2024. During the work week ending on March 28, 2025, Ontex repurchased 112,560 shares on the regulated market of Euronext Brussels, as set out in the table below. Date# sharesAverage price (in €)Minimum price (in €)Maximum ...
Rapportering betreffende inkoop van eigen aandelen
Rapportering betreffende inkoop van eigen aandelen Gereglementeerde informatie Aalst, België, 31 maart 2025 – In overeenstemming met artikel 8:4 van het Koninklijk Besluit tot uitvoering van het Wetboek van Vennootschappen en Verenigingen, maakt Ontex informatie bekend in verband met zijn programma om eigen aandelen in de kopen, dat was aangekondigd op 25 november 2024. In de loop van de werkweek eindigend op 28 maart 2025, werden 112.560 eigen aandelen ingekocht op de gereguleerde markt van Euronext Brussel, volgens het hieronder beschreven schema. Datum# aandelenGemiddel...
EXMAR NV: 1 director
A director at EXMAR NV bought 2,375,542 shares at 11.500EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- Carole Braudeau
Credit Morning 03/28/2025
The automotive sector strongly affected by tariffs announcements|Ubisoft to sell a 25% stake in a new entity owning its best assets to Tencent for € 1.16bn|Emeria: many uncertainties remain after the investor call|Atalian : 20% drop in EBITDA in Q4 24 and surprise departure of CEO|
- Carole Braudeau
Morning Crédit 28/03/2025
Le secteur auto fortement touché par les annonces de droits de douane|Ubisoft va céder 25% d’une entité regroupant ses meilleurs actifs à Tencent pour 1,16 md EUR|Emeria : beaucoup d’incertitudes persistent après le call investisseurs|Atalian : chute de -20% de l’EBITDA au T4 24 et départ surprise du CEO|
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Sharad Kumar S.P
- Thomas Couvreur
- Wim Hoste
- Markus Schmitt
Ontex : Following bond issuance: We are Stable/Neutral
Following the pricing of the new senior unsecured bond due 2030, we adopt a Neutral recommendation as the new bond is already indicated above par. We are also Neutral on the existing bond until the piece is fully redeemed. We change our Credit Opinion to Stable from Positive. Ontex has the chance to become a Ba3/BB- risk in the next two years, but at the same time its net leverage guidance is “below 3x” from today 2.4x pro forma the transaction. We believe there will be shareholder distributions...
- Markus Schmitt
Ontex : Following bond issuance: We are Stable/Neutral
Following the pricing of the new senior unsecured bond due 2030, we adopt a Neutral recommendation as the new bond is already indicated above par. We are also Neutral on the existing bond until the piece is fully redeemed. We change our Credit Opinion to Stable from Positive. Ontex has the chance to become a Ba3/BB- risk in the next two years, but at the same time its net leverage guidance is “below 3x” from today 2.4x pro forma the transaction. We believe there will be shareholder distributions...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.